Overexpressed lipoprotein lipase protects against atherosclerosis in apolipoprotein E knockout mice

Journal of Lipid Research

Volumn 40, Issue 9, 1999, Pages 1677-1685

  Yagyu, Hiroaki ^a   Ishibashi, Shun ^a   Chen, Zhong ^a   Osuga, Jun Ichi ^a   Okazaki, Mitsuyo ^b   Perrey, Stéphane ^a   Kitamine, Tetsuya ^a   Shimada, Masako ^a   Ohashi, Ken ^a   Harada, Kenji ^a   Shionoiri, Futoshi ^a   Yahagi, Naoya ^a   Gotoda, Takanari ^a   Yazaki, Yoshio ^a   Yamada, Nobuhiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Apolipoprotein A I; Apolipoprotein A IV; Apolipoprotein E; Atherosclerosis; Cholesterol; Foam cells; Knockout mice; Lipoprotein lipase; Remnant lipoproteins; Triglycerides

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CONTROLLED STUDY; ENZYME ASSAY; GENE OVEREXPRESSION; HYPERCHOLESTEROLEMIA; KNOCKOUT MOUSE; LIPID METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032847139     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Brunzell, J. D. 1995. Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In The Metabolic and Molecular Basis of Inherited Disease. R. S. Scriver, A. L. Beaudet, W. S. Sly, D. Valli, editors. McGraw-Hill Book Co., New York. 1913-1932.
2. Eckel, R. H. 1989. Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N. Engl. J. Med. 320: 1060-1068.
3. Goldberg, I. J. 1996. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37: 693-707.
4. Zilversmit, D. B. 1973. A proposal linking atherosclerosis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ. Res. 33: 633-638.
5. Benlian, P., J. Luc De Gennes, L. Foubert, H. Zhang, S. E. Gagne, and M. Hayden. 1996. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N. Engl. J. Med. 335: 848-854.
6. Reymer, P. W. A., E. Gagne, B. E. Groenemeyer, H. Zhang, I. Forsyth, H. Jansen, J. C. Seidell, D. Kromhout, K. E. Lie, J. Kastelein, and M. R. Hayden. 1995. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis, Nat. Genet. 10: 28-34.
7. Jukema, J. W., A. J. van Boven, B. Groenemeijer, A. H. Zwinderman, J. H. Reiber, A. V. Bruschke, J. A. Henneman, G. P. Molhoek, T. Bruin, H. Jansen, E. Gagne, M. R. Hayden, and J. J. Kastelein. 1996. The Asp9 Asn mutation in the lipoprotein lipase gene is associated with increased progression of coronary atherosclerosis. REGRESS Study Group, Interuniversity Cardiology Institute, Utrecht, The Netherlands. Regression Growth Evaluation Statin Study. Circulation. 94: 1913-1918.
8. Wittrup, H. H., A. Tybjörg-Hansen, S. Abildgaard, R. Steffensen, P. Schnohr, and B. G. Nordestgaard. 1997. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J. Clin. Invest. 99: 1606-1613.
9. Nordestgaard, B. G., S. Abildgaard, H. H. Wittrup, R. Steffensen, G. Jensen, and A. Tybjaerg-Hansen. 1997. Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease. Circulation. 96: 1737-1744.
10. Frick, M. H., O. Elo, K. Haapa, O. P. Heinonen, P. Heinsalmi, P. Helo, J. K. Huttunen, P. Kaitaniemi, P. Koskinen, V. Manninen, H. Mäenpää, M. Mälkönen, M. Mänttäri, S. Norola, A. Pasternack, J. Pikkarainen, M. Romo, T. Sjöblom, and E. A. Nikkilä. 1987. Helsinki heart study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N. Engl. J. Med. 317:1237-1245.
11. Manninen, V., L. Tenkanen, P. Koskinen, J. K. Huttunen, M. Mänttäri, O. P. Heinonen, and M. H. Frick. 1992. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki heart study. Implication for treatment. Circulation. 85: 37-45.
12. Ericsson, C-G., A. Hamsten, J. Nilsson, L. Grip, B. Svane, and U. de Faire. 1996. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet. 347: 849-853.
13. Shimada, M., H. Shimano, T. Gotoda, K. Yamamoto, M. Kawamura, T. Inaba, Y. Yazaki, and N. Yamada. 1993. Overexpression of human lipoprotein lipase in transgenic mice. Resistance to diet-induced hypertriglyceridemia and hypercholesterolemia. J. Biol. Chem. 268: 17924-17929.
14. Shimada, M., S. Ishibashi, T. Inaba, H. Yagyu, K. Harada, J-i. Osuga, K. Ohashi, Y. Yazaki, and N. Yamada. 1996. Suppression of diet-induced atherosclerosis in low density lipoprotein receptor knockout mice overexpressing lipoprotein lipase. Proc. Natl. Acad. Sci. USA. 93: 7242-7246.
15. Beisiegel, U., W. Weber, and G. Bengtsson-Olivecrona. 1991. Lipoprotein lipase enhances the binding of chylomicrons to low density lipoprotein receptor-related protein. Proc. Natl. Acad. Sci. USA. 88: 8342-8346.
16. Willnow, T., J. L. Goldstein, K. Orth, M. S. Brown, and J. Herz. 1992. Low density lipoprotein receptor-related protein (LRP) and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J. Biol. Chem. 267: 26172-26180.
17. Chappell, D. A., G. L. Fry, M. A. Waknitz, P-H. Iverius, S. E. Williams, and D.K. Strickland. 1992. The low density lipoprotein receptor-related protein/α2-macroglobulin receptor binds and mediates catabolism of bovine milk lipoprotein lipase. J. Biol. Chem. 267: 25764-25767.
18. Nykjaer, A., G. Bengstsson-Olivecrona, A. Lookene, S. K. Moestrup, C. M. Petersen, W. Weber, U. Beisiegel, and J. Gliemann. 1993. The α2-macroglobulin receptor/low density lipoprotein receptor-related protein binds lipoprotein lipase and β-migrating very low density lipoprotein associated with the lipase. J. Biol. Chem. 268: 15048-15055.
19. Chappell, D. A., G. L. Fry, M. A. Waknitz, L. E. Muhonen, M. W. Pladet, P-H. Iverius, and D. K. Strickland. 1993. Lipoprotein lipase induces catabolism of normal triglyceride-rich lipoproteins via the low density lipoprotein receptor-related protein/α2-macroglobulin receptor in vitro. A process facilitated by cell-surface proteoglycans. J. Biol. Chem. 268: 14168-14175.
20. Zhang, S. H., R. L. Reddick, J. A. Piedrahita, and N. Maeda. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258: 468-471.
21. Plump, A. S., J. D. Smith, T. Hayek, K. Aalto-Setala, A. Walsh, J. G. Verstuyft, E. M. Rubin, and J. L. Breslow. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71: 343-353.
22. Kawamura, M., H. Shimano, T. Gotoda, K. Harada, M. Shimada, J. Ohsuga, T. Inaba, Y. Watanabe, K. Yamamoto, K. Kozaki, Y. Yazaki, and N. Yamada. 1994. Overexpression of human lipoprotein lipase enhances uptake of lipoproteins containing apolipoprotein B-100 in transfected cells. Arterioscler. Thromb. 14: 235-242.
23. Havel, R. J., H. A. Eder, and J. H. Bragdon. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34: 1345-1353.
24. Noma, A., T. Yokosuka, and K. Kitamura. 1983. Plasma lipids and apolipoproteins as determinatiors for presence and severity of angiographycally defined coronary artery disease. Atherosclerosis. 49: 1-7.
25. Osuga, J-J., M. Yonemoto, N. Yamada, H. Shimano, H. Yagyu, K. Ohashi, K. Harada, T. Kamei, Y. Yazaki, and S. Ishibashi. 1998. Cholesterol lowering in low density lipoprotein receptor knockout mice overexpressing apolipoprotein E. J. Clin. Invest. 102: 386-394.
26. Bergeron, N., L. Kotite, and R. J. Havel. 1996. Simultaneous quantification of apolipoprotein B-100, B-48, and E separated by SDS-PAGE. Methods Enzymol. 262: 82-94.
27. Okazaki, M., K. Sasamoto, T. Muramatsu, and S. Hosaki. 1997. Analysis of plasma lipoproteins by gel permeation chromatography. In Handbook of Lipoprotein Testing. N. Rifai, G. R. Warnick, and M. H. Dominiczk, editors. AACC Press, Washington, DC. 531-548.
28. Okazaki, M., N. Komoriya, H. Tomoike, N. Inoue, S. Usui, S. Itoh, and S. Hosaki. 1998. Quantitative detection method of triglycerides in serum lipoproteins and serum-free glycerol high-performance liquid chromatography. J. Chromatogr. 709: 179-187.
29. Ishibashi, S., J. L. Goldstein, M. S. Brown, J. Herz, and D. K. Burns. 1994. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93: 1885-1893.
30. Tangirala, R. K., E. M. Rubin, and W. Palinski. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of the lesions between sexes in LDL receptor-deficient and apoE-deficient mice. J. Lipid Res. 36: 2320-2328.
31. Paigen, B., A. Morrow, P. A. Holmes, D. Mitchell, and R. A. Williams. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68: 231-240.
32. Lowry, O. H., N. J. Rosenbrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-275.
33. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
34. Zhang, S. H., R. L. Reddick, B. Burkey, and N. Maeda. 1994. Diet-induced atherosclerosis in mice heterozygous and homozygous for apolipoprotein E gene disruption. J. Clin. Invest. 94: 937-945.
35. Spangenberg, J., and L. K. Curtiss. 1997. Influence of macrophage-derived apoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apoprotein E-deficient mice. Biochem. Biophys. Acta. 1349: 109-121.
36. Rubin, E. M., R. M. Krauss, E. A. Spangler, J. G. Verstuyft, and S. M. Clift. 1991. Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI. Nature. 353: 265-267.
37. Paszty, C., N. Maeda, J. Verstuyft, and E. M. Rubin. 1994. Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94: 899-903.
38. Plump, A. S., C. J. Scott, and J. L. Breslow. 1994. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 91: 9607-9611.
39. Duverger, N., G. Tremp, J-M. Caillaud, F. Emmanuel, G. Castro, J-C. Fruchart, A. Steinmetz, and P. Denefle. 1996. Protection against atherosclerosis in mice mediated by human apolipoprotein A-IV. Science. 273: 966-968.
40. Cohen, R. D., L. W. Castellani, H. Qiao, B. J. Van Lenrten, A. J. Lusis, and K. Reue. 1997. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV. J. Clin. Invest. 99: 1906-1916.
41. Austin, M. A. 1991. Plasma triglyceride and coronary heart disease. Arterioscler. Thromb. 11: 2-14.
42. Eisenberg, S. 1984. High density lipoprotein metabolism. J. Lipid Res. 25: 1017-1058.
43. Liu, M-S., F. R. Jirik, R. C. LeBoeuf, H. Henderson, L. W. Castellani, A. J. Lusis, Y. Ma, I. J. Forsythe, H. Zhang, E. Kirk, J. D. Brunzell, and M. R. Hayden. 1994. Alteration of lipid profiles in plasma of transgenic mice expressing human lipoprotein lipase. J. Biol. Chem. 269: 11417-11424.
44. Zsigmond, E., E. Scheffler, T. M. Forte, R. Potenz, W. Wu, and L. Chan. 1994. Transgenic mice expressing human lipoprotein lipase driven by the mouse metallothionein promoter. A phenotype associated with increased perinatal mortality and reduced plasma very low density lipoprotein of normal size. J. Biol. Chem. 269: 18757-18766.
45. Levak-Frank, S., H. Radner, A. Walsh, R. Stollberger, G. Knipping, G. Hoefler, W. Sattler, P. H. Weinstock, J. L. Breslow, and R. Zechner. 1995. Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice. J. Clin. Invest. 96: 976-986.
46. Levak-Frank, S., P. H. Weinstock, T. Hayek, R. Verdery, W. Hofmann, R. Ramakrishnan, W. Sattler, J. L. Breslow, and R. Zechner. 1997. Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasma. J. Biol. Chem. 272: 17182-17190.
47. Brown, M., and J. L. Goldstein. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science. 232: 34-47.
48. Brown, M., J. Herz, R. C. Kowal, and J. L. Goldstein. 1991. The low density lipoprotein receptor-related protein: double agent or decoy? Curr. Opin. Lipidol. 2: 65-72.
49. Ishibashi, S., N. Yamada, H. Shimano, N. Mori, H. Mokuno, T. Gotoda, M. Kawakami, T. Murase, and F. Takaku. 1990. Apolipoprotein E and lipoprotein lipase secreted from human monocyte-derived macrophages modulate very low density lipoprotein uptake. J. Biol. Chem. 265: 3040-3047.
50. Saxena, U., M. G. Klein, T. M. Vanni, and I. J. Goldberg. 1992. Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix. J. Clin. Invest. 89: 373-380.
51. Eisenberg, S., E. Sehayek, T. Olivecrona, and I. Vlodavsky. 1992. Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix. J. Clin. Invest. 90: 2013-2021.